AstraZeneca shares fall 2.1% on Monday

Note: This section contains information in English only.
Source: Dukascopy Bank SA
On Monday, shares in UK's AstraZeneca were down 2.1% after a report that the firm had approached its US rival Gilead Sciences about a potential merger with the intention to form the world's biggest drug company.

Actual Topics